SCHEMA Computational Design of Virus Capsid Chimeras: Calibrating How Genome Packaging, Protection, and Transduction Correlate with Calculated Structural Disruption
- 22 August 2013
- journal article
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 2 (12) , 724-733
Abstract
Adeno-associated virus (AAV) recombination can result in chimeric capsid protein subunits whose ability to assemble into an oligomeric capsid, package a genome, and transduce cells depends on the inheritance of sequence from different AAV parents. To develop quantitative design principles for guiding site-directed recombination of AAV capsids, we have examined how capsid structural perturbations predicted by the SCHEMA algorithm correlate with experimental measurements of disruption in seventeen chimeric capsid proteins. In our small chimera population, created by recombining AAV serotypes 2 and 4, we found that protection of viral genomes and cellular transduction were inversely related to calculated disruption of the capsid structure. Interestingly, however, we did not observe a correlation between genome packaging and calculated structural disruption; a majority of the chimeric capsid proteins formed at least partially assembled capsids and more than half packaged genomes, including those with the highest SCHEMA disruption. These results suggest that the sequence space accessed by recombination of divergent AAV serotypes is rich in capsid chimeras that assemble into 60-mer capsids and package viral genomes. Overall, the SCHEMA algorithm may be useful for delineating quantitative design principles to guide the creation of libraries enriched in genome-protecting virus nanoparticles that can effectively transduce cells. Such improvements to the virus design process may help advance not only gene therapy applications but also other bionanotechnologies dependent upon the development of viruses with new sequences and functions.Keywords
This publication has 52 references indexed in Scilit:
- SCHEMA-Designed Variants of Human Arginase I and II Reveal Sequence Elements Important to Stability and CatalysisACS Synthetic Biology, 2012
- Directed Evolution of Adeno-associated Virus for Enhanced Gene Delivery and Gene Targeting in Human Pluripotent Stem CellsMolecular Therapy, 2012
- Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of InfectivityMolecular Therapy Nucleic Acids, 2012
- An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem CellsMolecular Therapy, 2011
- Viral nanoparticles as platforms for next-generation therapeutics and imaging devicesNanomedicine: Nanotechnology, Biology and Medicine, 2010
- A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect CellsMolecular Therapy, 2009
- Directed evolution of adeno-associated virus for glioma cell transductionJournal of Neuro-Oncology, 2009
- Adeno-associated virus-2 and its primary cellular receptor—Cryo-EM structure of a heparin complexVirology, 2009
- Diversification of Catalytic Function in a Synthetic Family of Chimeric Cytochrome P450sChemistry & Biology, 2007
- Protein building blocks preserved by recombinationNature Structural & Molecular Biology, 2002